Adverse Drug Reaction Classification System

ADR Ontology
ADR Term X-linked lymphoproliferative syndrome
ADR ID BADD_A06511
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.02      Lymphoproliferative disorders NEC (excl leukaemias and lymphomas)
01.13.02.003      X-linked lymphoproliferative syndrome
03      Congenital, familial and genetic disorders
03.17      Immune system disorders congenital
03.17.01      Immune system abnormalities congenital
03.17.01.002      X-linked lymphoproliferative syndrome
10      Immune system disorders
10.03      Immunodeficiency syndromes
10.03.01      Primary immunodeficiency syndromes
10.03.01.003      X-linked lymphoproliferative syndrome
11      Infections and infestations
11.05      Viral infectious disorders
11.05.10      Epstein-Barr viral infections
11.05.10.005      X-linked lymphoproliferative syndrome
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.02      Lymphoproliferative disorders NEC (excl leukaemias and lymphomas)
16.21.02.003      X-linked lymphoproliferative syndrome
Description Disorders characterized by proliferation of lymphoid tissue, general or unspecified. [MeSH]
MedDRA Code 10068348
MeSH ID D008232
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
X-linked lymphoproliferative syndrome | Duncan syndrome | Lymphoproliferative Disorders | Disorder, Lymphoproliferative | Disorders, Lymphoproliferative | Lymphoproliferative Disorder | X-Linked Lymphoproliferative Disorder | Disorder, X-Linked Lymphoproliferative | Disorders, X-Linked Lymphoproliferative | Lymphoproliferative Disorder, X-Linked | Lymphoproliferative Disorders, X-Linked | X Linked Lymphoproliferative Disorder | X-Linked Lymphoproliferative Disorders | Epstein-Barr Virus Infection, Familial Fatal | Epstein Barr Virus Infection, Familial Fatal | Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males | Epstein Barr Virus Induced Lymphoproliferative Disease In Males | Familial Fatal Epstein-Barr Infection | Familial Fatal Epstein Barr Infection | Immunodeficiency 5 | Immunodeficiency 5s | Duncan's Syndrome | Lymphoproliferative Disease, X-Linked | Disease, X-Linked Lymphoproliferative | Diseases, X-Linked Lymphoproliferative | Lymphoproliferative Disease, X Linked | Lymphoproliferative Diseases, X-Linked | X-Linked Lymphoproliferative Diseases | Lymphoproliferative Syndrome, X-Linked, 1 | Purtilo Syndrome | Purtilo Syndromes | Syndrome, Purtilo | Syndromes, Purtilo | X-Linked Lymphoproliferative Disease | X Linked Lymphoproliferative Disease | X-Linked Lymphoproliferative Syndrome | Lymphoproliferative Syndrome, X-Linked | Lymphoproliferative Syndromes, X-Linked | Syndrome, X-Linked Lymphoproliferative | Syndromes, X-Linked Lymphoproliferative | X Linked Lymphoproliferative Syndrome | X-Linked Lymphoproliferative Syndromes | Duncan Disease | Disease, Duncan | Immunodeficiency, X-Linked Progressive Combined Variable | Immunodeficiency, X Linked Progressive Combined Variable
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine--
BADD_D00551Cyclosporine--
BADD_D00858Everolimus--
BADD_D00871Felbamate--
BADD_D00899Fingolimod hydrochloride--
BADD_D00914Fludarabine--
BADD_D00915Fludarabine phosphate--
BADD_D01418Methotrexate--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid--
BADD_D01858Propagermanium--
BADD_D02028Sirolimus--
BADD_D02105Tacrolimus--
The 1th Page    1    Total 1 Pages